(Q40066641)

English

Phorbol ester-induced shedding of the prostate cancer marker transmembrane protein with epidermal growth factor and two follistatin motifs 2 is mediated by the disintegrin and metalloproteinase-17.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Phorbol ester-induced shedding of the prostate cancer marker transmembrane protein with epidermal growth factor and two follistatin motifs 2 is mediated by the disintegrin and metalloproteinase-17. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

transmembrane protein

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Nazim Ali

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Vera Knaüper

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

language of work or name

0 references

publication date

17 October 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

282

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

37378-37388

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Identification and characterization of TMEFF2, a novel survival factor for hippocampal and mesencephalic neurons

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Tomoregulin-2 is found extensively in plaques in Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Tomoregulin ectodomain shedding by proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

ADAMs: key components in EGFR signalling and development

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1)

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Furin-, ADAM 10-, and gamma-secretase-mediated cleavage of a receptor tyrosine phosphatase and regulation of beta-catenin's transcriptional activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Regulated ADAM10-dependent ectodomain shedding of gamma-protocadherin C3 modulates cell-cell adhesion

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Breaking up the tie: disintegrin-like metalloproteinases as regulators of cell migration in inflammation and invasion.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

EGFR signal transactivation in cancer cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

TIMP-3 deficiency leads to dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Targeting ADAMS and ERBBs in lung cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Emerging roles of TACE as a key protease in ErbB ligand shedding

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

The membrane-anchoring domain of epidermal growth factor receptor ligands dictates their ability to operate in juxtacrine mode

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

TACE is required for the activation of the EGFR by TGF-alpha in tumors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Oncogenic growth factor receptors: implications for signal transduction therapy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Shedding of the amyloid precursor protein-like protein APLP2 by disintegrin-metalloproteinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Intramembrane proteolysis by presenilin and presenilin-like proteases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Evidence for a critical role of the tumor necrosis factor alpha convertase (TACE) in ectodomain shedding of the p75 neurotrophin receptor (p75NTR).

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Proteolytic release of membrane-bound angiotensin-converting enzyme: role of the juxtamembrane stalk sequence

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

ADAMs, cell migration and cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Targeting TACE-dependent EGFR ligand shedding in breast cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosterone

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Post-transcriptional up-regulation of ADAM17 upon epidermal growth factor receptor activation and in breast tumors.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

The immunoglobulin-like domain is involved in interaction of Neuregulin1 with ErbB.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Targeting tomoregulin for radioimmunotherapy of prostate cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

A truncated isoform of TMEFF2 encodes a secreted protein in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Protein interaction analysis of ST14 domains and their point and deletion mutants

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M702170200

21 January 2018

Identifiers

10.1074/JBC.M702170200

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40066641&oldid=1966874165"